ReP USP - Resultado da busca

Artigo de periodico
Semisynthetic p-coumaric acid derivatives as leadDual inhibitors against DPP-IV and GSK-3β for antidiabetic therapy (2024)
Paula, Heberth de ; Bolsoni, Camilla Santos; Souza, Fernanda Fernandes de; Fonseca, Victor da Rocha ; Romão, Wanderson ; Sairre, Mirela Inês de ; Honorio, Kathia Maria ; Lacerda Jr., Valdemar ; Morais, Pedro Alves Bezerra
Fonte: Chemical Biology and Drug Design. Unidade: EACH
Assuntos: DIABETES MELLITUS, DIABETES MELLITUS, INIBIDORES DE ENZIMAS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAULA, Heberth de et al. Semisynthetic p-coumaric acid derivatives as leadDual inhibitors against DPP-IV and GSK-3β for antidiabetic therapy. Chemical Biology and Drug Design, v. No 2024, n. 5, p. 01-15, 2024Tradução . . Disponível em: http://dx.doi.org/10.1111/cbdd.70016. Acesso em: 08 out. 2025.
APA
Paula, H. de, Bolsoni, C. S., Souza, F. F. de, Fonseca, V. da R., Romão, W., Sairre, M. I. de, et al. (2024). Semisynthetic p-coumaric acid derivatives as leadDual inhibitors against DPP-IV and GSK-3β for antidiabetic therapy. Chemical Biology and Drug Design, No 2024( 5), 01-15. doi:10.1111/cbdd.70016
NLM
Paula H de, Bolsoni CS, Souza FF de, Fonseca V da R, Romão W, Sairre MI de, Honorio KM, Lacerda Jr. V, Morais PAB. Semisynthetic p-coumaric acid derivatives as leadDual inhibitors against DPP-IV and GSK-3β for antidiabetic therapy [Internet]. Chemical Biology and Drug Design. 2024 ; No 2024( 5): 01-15.[citado 2025 out. 08 ] Available from: http://dx.doi.org/10.1111/cbdd.70016
Vancouver
Paula H de, Bolsoni CS, Souza FF de, Fonseca V da R, Romão W, Sairre MI de, Honorio KM, Lacerda Jr. V, Morais PAB. Semisynthetic p-coumaric acid derivatives as leadDual inhibitors against DPP-IV and GSK-3β for antidiabetic therapy [Internet]. Chemical Biology and Drug Design. 2024 ; No 2024( 5): 01-15.[citado 2025 out. 08 ] Available from: http://dx.doi.org/10.1111/cbdd.70016
Artigo de periodico
Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum (2024)
Lapierre, Thibault Joseph William Jacques Dit ; Farago, Danilo Nascimento; Cruz, Mariza Gabriela Faleiro de Moura Lodi; Resende, Daniela de Melo ; Oliveira, Adriane Cristina Rosa de; Santos, Brenda Rosa Macedo dos; Souza, Felipe de Oliveira; Duarte, Simone Michelan ; Chelucci, Rafael Consolin; Andricopulo, Adriano Defini ; Ferreira, Leonardo Luiz Gomes ; Pilau, Eduardo Jorge ; Murta, Silvane Maria Fonseca ; Rezende Junior, Celso de Oliveira
Fonte: Chemical Biology and Drug Design. Unidade: IFSC
Assuntos: LEISHMANIA, MECANISMOS DE DEFESA, TRYPANOSOMA CRUZI
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAPIERRE, Thibault Joseph William Jacques Dit et al. Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum. Chemical Biology and Drug Design, v. 103, p. e14525-1-e14525-14 + supporting information, 2024Tradução . . Disponível em: https://doi.org/10.1111/cbdd.14525. Acesso em: 08 out. 2025.
APA
Lapierre, T. J. W. J. D., Farago, D. N., Cruz, M. G. F. de M. L., Resende, D. de M., Oliveira, A. C. R. de, Santos, B. R. M. dos, et al. (2024). Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum. Chemical Biology and Drug Design, 103, e14525-1-e14525-14 + supporting information. doi:10.1111/cbdd.14525
NLM
Lapierre TJWJD, Farago DN, Cruz MGF de ML, Resende D de M, Oliveira ACR de, Santos BRM dos, Souza F de O, Duarte SM, Chelucci RC, Andricopulo AD, Ferreira LLG, Pilau EJ, Murta SMF, Rezende Junior C de O. Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum [Internet]. Chemical Biology and Drug Design. 2024 ; 103 e14525-1-e14525-14 + supporting information.[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/cbdd.14525
Vancouver
Lapierre TJWJD, Farago DN, Cruz MGF de ML, Resende D de M, Oliveira ACR de, Santos BRM dos, Souza F de O, Duarte SM, Chelucci RC, Andricopulo AD, Ferreira LLG, Pilau EJ, Murta SMF, Rezende Junior C de O. Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum [Internet]. Chemical Biology and Drug Design. 2024 ; 103 e14525-1-e14525-14 + supporting information.[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/cbdd.14525
Editor de periodico
Chemical Biology and Drug Design (2022)
Selwood, David (Editor); Montanari, Carlos Alberto (Editor)
Fonte: Chemical Biology and Drug Design. Unidade: IQSC
Assuntos: BIOQUÍMICA, BIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Disponível em: https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html. Acesso em: 08 out. 2025. , 2022
APA
Chemical Biology and Drug Design. (2022). Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Recuperado de https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html
NLM
Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2022 ;[citado 2025 out. 08 ] Available from: https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html
Vancouver
Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2022 ;[citado 2025 out. 08 ] Available from: https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html
Artigo de periodico
Design, synthesis and antitrypanosomatid activities of 3,5-diaryl-isoxazole analogues based on neolignans veraguensin, grandisin and machilin G (2019)
Trefzger, Ozildeia S; Neves, Amarith R. das; Barbosa, Natalia V; Carvalho, Diego B; Pereira, Indiara C; Perdomo, Renata T; Matos, Maria F. C; Yoshida, Nidia C; Kato, Massuo Jorge ; Albuquerque, Sérgio de; Arruda, Carla C. P; Baroni, Adriano C. M
Fonte: Chemical Biology and Drug Design. Unidades: IQ, FCFRP
Assuntos: FITOQUÍMICA, ANTIPROTOZOÁRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TREFZGER, Ozildeia S et al. Design, synthesis and antitrypanosomatid activities of 3,5-diaryl-isoxazole analogues based on neolignans veraguensin, grandisin and machilin G. Chemical Biology and Drug Design, v. 93, n. 3, p. 313-324, 2019Tradução . . Disponível em: https://doi.org/10.1111/cbdd.13417. Acesso em: 08 out. 2025.
APA
Trefzger, O. S., Neves, A. R. das, Barbosa, N. V., Carvalho, D. B., Pereira, I. C., Perdomo, R. T., et al. (2019). Design, synthesis and antitrypanosomatid activities of 3,5-diaryl-isoxazole analogues based on neolignans veraguensin, grandisin and machilin G. Chemical Biology and Drug Design, 93( 3), 313-324. doi:10.1111/cbdd.13417
NLM
Trefzger OS, Neves AR das, Barbosa NV, Carvalho DB, Pereira IC, Perdomo RT, Matos MFC, Yoshida NC, Kato MJ, Albuquerque S de, Arruda CCP, Baroni ACM. Design, synthesis and antitrypanosomatid activities of 3,5-diaryl-isoxazole analogues based on neolignans veraguensin, grandisin and machilin G [Internet]. Chemical Biology and Drug Design. 2019 ; 93( 3): 313-324.[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/cbdd.13417
Vancouver
Trefzger OS, Neves AR das, Barbosa NV, Carvalho DB, Pereira IC, Perdomo RT, Matos MFC, Yoshida NC, Kato MJ, Albuquerque S de, Arruda CCP, Baroni ACM. Design, synthesis and antitrypanosomatid activities of 3,5-diaryl-isoxazole analogues based on neolignans veraguensin, grandisin and machilin G [Internet]. Chemical Biology and Drug Design. 2019 ; 93( 3): 313-324.[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/cbdd.13417
Editor de periodico
Chemical Biology and Drug Design (2019)
Selwood, David (Editor); Montanari, Carlos Alberto (Editor)
Fonte: Chemical Biology and Drug Design. Unidade: IQSC
Assuntos: BIOQUÍMICA, BIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Disponível em: https://repositorio.usp.br/directbitstream/823d6fdb-0e41-4168-8a43-02c997fca1fc/P17911.pdf. Acesso em: 08 out. 2025. , 2019
APA
Chemical Biology and Drug Design. (2019). Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Recuperado de https://repositorio.usp.br/directbitstream/823d6fdb-0e41-4168-8a43-02c997fca1fc/P17911.pdf
NLM
Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2019 ;[citado 2025 out. 08 ] Available from: https://repositorio.usp.br/directbitstream/823d6fdb-0e41-4168-8a43-02c997fca1fc/P17911.pdf
Vancouver
Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2019 ;[citado 2025 out. 08 ] Available from: https://repositorio.usp.br/directbitstream/823d6fdb-0e41-4168-8a43-02c997fca1fc/P17911.pdf
Artigo de periodico
Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening (2018)
Meissner, Kamila Anna ; Kronenberger, Thales ; Maltarollo, Vinícius Gonçalves ; Trossini, Gustavo Henrique Goulart ; Wrenger, Carsten
Fonte: Chemical Biology and Drug Design. Unidades: FCF, ICB
Assuntos: PLASMODIUM FALCIPARUM, PARASITOLOGIA, MALÁRIA, QUIMIOTERAPIA, ENZIMAS PROTEOLITICAS, ATIVAÇÃO ENZIMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEISSNER, Kamila Anna et al. Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening. Chemical Biology and Drug Design, v. 2018 p. 1-13, 2018Tradução . . Disponível em: https://doi.org/10.1111/cbdd.13416. Acesso em: 08 out. 2025.
APA
Meissner, K. A., Kronenberger, T., Maltarollo, V. G., Trossini, G. H. G., & Wrenger, C. (2018). Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening. Chemical Biology and Drug Design, 2018 p. 1-13. doi:10.1111/cbdd.13416
NLM
Meissner KA, Kronenberger T, Maltarollo VG, Trossini GHG, Wrenger C. Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening [Internet]. Chemical Biology and Drug Design. 2018 ; 2018 p. 1-13[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/cbdd.13416
Vancouver
Meissner KA, Kronenberger T, Maltarollo VG, Trossini GHG, Wrenger C. Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening [Internet]. Chemical Biology and Drug Design. 2018 ; 2018 p. 1-13[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/cbdd.13416
Artigo de periodico
Molecular description of α-keto-based inhibitors of cruzain with activity against Chagas disease combining 3D-QSAR studies and molecular dynamics (2018)
Saraiva, Ádria P. B.; Miranda, Ricardo M.; Valente, Renan P. P.; Araújo, Jéssica O.; Souza, Rutelene N. B.; Costa, Clauber H. S.; Oliveira, Amanda R. S.; Almeida, Michell O.; Figueiredo, Antonio F.; Ferreira, João E. V.; Alves, Cláudio Nahum; Honorio, Káthia Maria
Fonte: Chemical Biology and Drug Design. Unidade: EACH
Assuntos: DOENÇA DE CHAGAS, QUÍMICA MÉDICA, RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SARAIVA, Ádria P. B. et al. Molecular description of α-keto-based inhibitors of cruzain with activity against Chagas disease combining 3D-QSAR studies and molecular dynamics. Chemical Biology and Drug Design, p. 01-13, 2018Tradução . . Disponível em: https://doi.org/10.1111/cbdd.13313. Acesso em: 08 out. 2025.
APA
Saraiva, Á. P. B., Miranda, R. M., Valente, R. P. P., Araújo, J. O., Souza, R. N. B., Costa, C. H. S., et al. (2018). Molecular description of α-keto-based inhibitors of cruzain with activity against Chagas disease combining 3D-QSAR studies and molecular dynamics. Chemical Biology and Drug Design, 01-13. doi:10.1111/cbdd.13313
NLM
Saraiva ÁPB, Miranda RM, Valente RPP, Araújo JO, Souza RNB, Costa CHS, Oliveira ARS, Almeida MO, Figueiredo AF, Ferreira JEV, Alves CN, Honorio KM. Molecular description of α-keto-based inhibitors of cruzain with activity against Chagas disease combining 3D-QSAR studies and molecular dynamics [Internet]. Chemical Biology and Drug Design. 2018 ; 01-13.[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/cbdd.13313
Vancouver
Saraiva ÁPB, Miranda RM, Valente RPP, Araújo JO, Souza RNB, Costa CHS, Oliveira ARS, Almeida MO, Figueiredo AF, Ferreira JEV, Alves CN, Honorio KM. Molecular description of α-keto-based inhibitors of cruzain with activity against Chagas disease combining 3D-QSAR studies and molecular dynamics [Internet]. Chemical Biology and Drug Design. 2018 ; 01-13.[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/cbdd.13313
Editor de periodico
Chemical Biology and Drug Design (2017)
Selwood, David (Editor); Montanari, Carlos Alberto (Editor)
Fonte: Chemical Biology and Drug Design. Unidade: IQSC
Assuntos: BIOQUÍMICA, BIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Wiley-Blackwell Publishing, Inc. Disponível em: https://repositorio.usp.br/directbitstream/7d5f144e-eeb7-48f5-b01d-9a5c9bacb874/P17700.pdf. Acesso em: 08 out. 2025. , 2017
APA
Chemical Biology and Drug Design. (2017). Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Wiley-Blackwell Publishing, Inc. Recuperado de https://repositorio.usp.br/directbitstream/7d5f144e-eeb7-48f5-b01d-9a5c9bacb874/P17700.pdf
NLM
Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2017 ;[citado 2025 out. 08 ] Available from: https://repositorio.usp.br/directbitstream/7d5f144e-eeb7-48f5-b01d-9a5c9bacb874/P17700.pdf
Vancouver
Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2017 ;[citado 2025 out. 08 ] Available from: https://repositorio.usp.br/directbitstream/7d5f144e-eeb7-48f5-b01d-9a5c9bacb874/P17700.pdf
Artigo de periodico
Quantum-chemistry descriptors for photosensitizers based on macrocycles (2017)
Bettanin, Fernanda; Antonio, Felipe C. T.; Honório, Káthia Maria; Homem-de-Mello, Paula
Fonte: Chemical Biology and Drug Design. Unidade: EACH
Assuntos: PORFIRINAS, QUÍMICA QUÂNTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BETTANIN, Fernanda et al. Quantum-chemistry descriptors for photosensitizers based on macrocycles. Chemical Biology and Drug Design, v. 89, n. 2, p. 207-220, 2017Tradução . . Disponível em: https://doi.org/10.1111/cbdd.12791. Acesso em: 08 out. 2025.
APA
Bettanin, F., Antonio, F. C. T., Honório, K. M., & Homem-de-Mello, P. (2017). Quantum-chemistry descriptors for photosensitizers based on macrocycles. Chemical Biology and Drug Design, 89( 2), 207-220. doi:10.1111/cbdd.12791
NLM
Bettanin F, Antonio FCT, Honório KM, Homem-de-Mello P. Quantum-chemistry descriptors for photosensitizers based on macrocycles [Internet]. Chemical Biology and Drug Design. 2017 ; 89( 2): 207-220.[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/cbdd.12791
Vancouver
Bettanin F, Antonio FCT, Honório KM, Homem-de-Mello P. Quantum-chemistry descriptors for photosensitizers based on macrocycles [Internet]. Chemical Biology and Drug Design. 2017 ; 89( 2): 207-220.[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/cbdd.12791
Artigo de periodico
Fragment- based drug discovery as alternative strategy to the drug development for neglected diseases (2017)
Mello, Juliana da Fonseca Rezende e; Gomes, Renan Augusto; Fujii, Drielli Gomes Vital; Ferreira, Glaucio Monteiro; Trossini, Gustavo Henrique Goulart
Fonte: Chemical Biology and Drug Design. Unidade: FCF
Assuntos: PLANEJAMENTO DE FÁRMACOS, DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELLO, Juliana da Fonseca Rezende e et al. Fragment- based drug discovery as alternative strategy to the drug development for neglected diseases. Chemical Biology and Drug Design, v. 90, n. 6. p. 1067-1078, 2017Tradução . . Disponível em: https://doi.org/10.1111/cbdd.13030. Acesso em: 08 out. 2025.
APA
Mello, J. da F. R. e, Gomes, R. A., Fujii, D. G. V., Ferreira, G. M., & Trossini, G. H. G. (2017). Fragment- based drug discovery as alternative strategy to the drug development for neglected diseases. Chemical Biology and Drug Design, 90( 6. p. 1067-1078). doi:10.1111/cbdd.13030
NLM
Mello J da FR e, Gomes RA, Fujii DGV, Ferreira GM, Trossini GHG. Fragment- based drug discovery as alternative strategy to the drug development for neglected diseases [Internet]. Chemical Biology and Drug Design. 2017 ; 90( 6. p. 1067-1078):[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/cbdd.13030
Vancouver
Mello J da FR e, Gomes RA, Fujii DGV, Ferreira GM, Trossini GHG. Fragment- based drug discovery as alternative strategy to the drug development for neglected diseases [Internet]. Chemical Biology and Drug Design. 2017 ; 90( 6. p. 1067-1078):[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/cbdd.13030
Artigo de periodico
MD simulations and multivariate studies for modeling the antileishmanial activity of peptides (2017)
Guerra, Mirian Elisa Rodrigues; Fadel, Valmir; Maltarollo, Vinícius Gonçalves; Baldissera, Gisele; Honório, Káthia Maria; Ruggiero, José Roberto; Cabrera, Marcia Perez dos Santos
Fonte: Chemical Biology and Drug Design. Unidade: EACH
Assuntos: RELAÇÕES ESTRUTURA-ATIVIDADE, RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA, PEPTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUERRA, Mirian Elisa Rodrigues et al. MD simulations and multivariate studies for modeling the antileishmanial activity of peptides. Chemical Biology and Drug Design, p. 1-10, 2017Tradução . . Disponível em: https://doi.org/10.1111/cbdd.12970. Acesso em: 08 out. 2025.
APA
Guerra, M. E. R., Fadel, V., Maltarollo, V. G., Baldissera, G., Honório, K. M., Ruggiero, J. R., & Cabrera, M. P. dos S. (2017). MD simulations and multivariate studies for modeling the antileishmanial activity of peptides. Chemical Biology and Drug Design, 1-10. doi:10.1111/cbdd.12970
NLM
Guerra MER, Fadel V, Maltarollo VG, Baldissera G, Honório KM, Ruggiero JR, Cabrera MP dos S. MD simulations and multivariate studies for modeling the antileishmanial activity of peptides [Internet]. Chemical Biology and Drug Design. 2017 ; 1-10.[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/cbdd.12970
Vancouver
Guerra MER, Fadel V, Maltarollo VG, Baldissera G, Honório KM, Ruggiero JR, Cabrera MP dos S. MD simulations and multivariate studies for modeling the antileishmanial activity of peptides [Internet]. Chemical Biology and Drug Design. 2017 ; 1-10.[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/cbdd.12970
Artigo de periodico
Synthesis, cytotoxicity and in vitro antileishmanial activity of naphthothiazoles (2013)
Toledo, Juliano S. de; Júnior, Paulo E. S.; Manfrim, Viviane; Pinzan, Camila F.; Araújo, Alexandre S. de; Cruz, Ângela Kaysel; Emery, Flavio da Silva
Fonte: Chemical Biology and Drug Design. Unidades: FCFRP, FMRP
Assuntos: LEISHMANIA BRASILIENSIS, ANTIPROTOZOÁRIOS, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOLEDO, Juliano S. de et al. Synthesis, cytotoxicity and in vitro antileishmanial activity of naphthothiazoles. Chemical Biology and Drug Design, v. 81, n. 6, p. 749-756, 2013Tradução . . Disponível em: https://doi.org/10.1111/cbdd.12123. Acesso em: 08 out. 2025.
APA
Toledo, J. S. de, Júnior, P. E. S., Manfrim, V., Pinzan, C. F., Araújo, A. S. de, Cruz, Â. K., & Emery, F. da S. (2013). Synthesis, cytotoxicity and in vitro antileishmanial activity of naphthothiazoles. Chemical Biology and Drug Design, 81( 6), 749-756. doi:10.1111/cbdd.12123
NLM
Toledo JS de, Júnior PES, Manfrim V, Pinzan CF, Araújo AS de, Cruz ÂK, Emery F da S. Synthesis, cytotoxicity and in vitro antileishmanial activity of naphthothiazoles [Internet]. Chemical Biology and Drug Design. 2013 ; 81( 6): 749-756.[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/cbdd.12123
Vancouver
Toledo JS de, Júnior PES, Manfrim V, Pinzan CF, Araújo AS de, Cruz ÂK, Emery F da S. Synthesis, cytotoxicity and in vitro antileishmanial activity of naphthothiazoles [Internet]. Chemical Biology and Drug Design. 2013 ; 81( 6): 749-756.[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/cbdd.12123
Artigo de periodico
Ligand- and structure-based drug design strategies and PPAR'delta'⁄'alfa' selectivity (2012)
Maltarollo, Vinícius Gonçalves; Honório, Kathia Maria
Fonte: Chemical Biology and Drug Design. Unidade: EACH
Assuntos: MODELAGEM MOLECULAR, QUÍMICA QUÂNTICA, RECEPTORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTAROLLO, Vinícius Gonçalves e HONÓRIO, Kathia Maria. Ligand- and structure-based drug design strategies and PPAR'delta'⁄'alfa' selectivity. Chemical Biology and Drug Design, 2012Tradução . . Disponível em: https://doi.org/10.1111/j.1747-0285.2012.01424.x. Acesso em: 08 out. 2025.
APA
Maltarollo, V. G., & Honório, K. M. (2012). Ligand- and structure-based drug design strategies and PPAR'delta'⁄'alfa' selectivity. Chemical Biology and Drug Design. doi:10.1111/j.1747-0285.2012.01424.x
NLM
Maltarollo VG, Honório KM. Ligand- and structure-based drug design strategies and PPAR'delta'⁄'alfa' selectivity [Internet]. Chemical Biology and Drug Design. 2012 ;[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/j.1747-0285.2012.01424.x
Vancouver
Maltarollo VG, Honório KM. Ligand- and structure-based drug design strategies and PPAR'delta'⁄'alfa' selectivity [Internet]. Chemical Biology and Drug Design. 2012 ;[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/j.1747-0285.2012.01424.x

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Grupo de pesquisa

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada